Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Hiroaki Tsujikawa"'
Autor:
Hiroaki Tsujikawa, Shunsuke Yamada, Hiroto Hiyamuta, Masatomo Taniguchi, Kazuhiko Tsuruya, Kumiko Torisu, Toshiaki Nakano, Takanari Kitazono
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Women have a longer life expectancy than men in the general population. However, it has remained unclear whether this advantage is maintained in patients undergoing maintenance hemodialysis. The aim of this study was to compare the risk of m
Externí odkaz:
https://doaj.org/article/72690ad02fcc4fea9e83ca3c85794be9
Autor:
Takaichi Suehiro, Kazuhiko Tsuruya, Hisako Yoshida, Hiroaki Tsujikawa, Shunsuke Yamada, Shigeru Tanaka, Akihiro Tsuchimoto, Masahiro Eriguchi, Kiichiro Fujisaki, Kumiko Torisu, Toshiaki Nakano, Takanari Kitazono
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-12 (2021)
Introduction: Angiotensin receptor blockers (ARBs) are preferably used in hypertensive patients with CKD. Azilsartan is a strong antihypertensive ARB, but its antiproteinuric effects are not well understood. We compared the antiproteinuric effect of
Externí odkaz:
https://doaj.org/article/29c044c419954432b6654bc229db75a3
Autor:
Hiroaki Tsujikawa, Shigeru Tanaka, Yuta Matsukuma, Hidetoshi Kanai, Kumiko Torisu, Toshiaki Nakano, Kazuhiko Tsuruya, Takanari Kitazono
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0213922 (2019)
BackgroundAssessment of infection-related mortality remains inadequate in patients undergoing peritoneal dialysis. This study was performed to develop a risk model for predicting the 2-year infection-related mortality risk in patients undergoing peri
Externí odkaz:
https://doaj.org/article/96761857a66543a9bcc4f54d5d0f115c
Autor:
Hokuto Arase, Shunsuke Yamada, Masatomo Taniguchi, Shotaro Ohnaka, Hiroaki Tsujikawa, Masanori Tokumoto, Takanari Kitazono, Kazuhiko Tsuruya, Toshiaki Nakano
Publikováno v:
Clinical Nutrition. 40:997-1004
Normalized protein catabolic rate (nPCR) is used as a surrogate for daily dietary protein intake and nutritional status in patients receiving maintenance hemodialysis. It remains uncertain whether the nPCR level is associated with the incidence of bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0b64f4ab5e8155c38c94b764c840bcd
https://doi.org/10.1016/j.clnu.2020.07.003
https://doi.org/10.1016/j.clnu.2020.07.003
Autor:
Toshiaki Nakano, Hokuto Arase, Hiroaki Tsujikawa, Takanari Kitazono, Shunsuke Yamada, Yasuhiro Kawai, Shoji Tsuneyoshi, Hisako Yoshida, Kazuhiko Tsuruya
Publikováno v:
Therapeutic Apheresis and Dialysis. 24:72-80
Preserving residual kidney function (RKF) is important in the management of patients on peritoneal dialysis. However, few studies have examined the association between serum albumin level and the risk of RKF loss. We prospectively recruited 104 patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e21fd72559fb8f6391d80e8e17de4574
https://doi.org/10.1111/1744-9987.12861
https://doi.org/10.1111/1744-9987.12861
Autor:
Shigeru Tanaka, Masahiro Eriguchi, Toshiaki Nakano, Takanari Kitazono, Kazuhiko Tsuruya, Hisako Yoshida, Shunsuke Yamada, Kumiko Torisu, Kiichiro Fujisaki, Akihiro Tsuchimoto, Takaichi Suehiro, Hiroaki Tsujikawa
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-12 (2021)
Introduction: Angiotensin receptor blockers (ARBs) are preferably used in hypertensive patients with CKD. Azilsartan is a strong antihypertensive ARB, but its antiproteinuric effects are not well understood. We compared the antiproteinuric effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b56f2f5d16199fa9b8ca064ab93a489
https://pubmed.ncbi.nlm.nih.gov/33677450
https://pubmed.ncbi.nlm.nih.gov/33677450
Autor:
Shigeru Tanaka, Hiroaki Tsujikawa, Kaneyasu Nakagawa, Masayoshi Okumi, Toshiaki Nakano, Yasuhiro Okabe, Keizo Kaku, Yuta Matsukuma, Kohei Unagami, Hiroshi Noguchi, Akihiro Tsuchimoto, Yoichi Kakuta, Takanari Kitazono, Masafumi Nakamura, Kazunari Tanabe, Kazuhiko Tsuruya, Kosuke Masutani, Kenji Ueki
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 36(2)
Background Cardiovascular disease (CVD) is a major cause of death in kidney transplant (KT) recipients. To improve their long-term survival, it is clinically important to estimate the risk of CVD after living donor KT via adequate pre-transplant CVD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a3cdafaa3dd607a26e571517969415
https://pubmed.ncbi.nlm.nih.gov/33367750
https://pubmed.ncbi.nlm.nih.gov/33367750
Autor:
Yasuhiro Kawai, Shigeru Tanaka, Kazuhiko Tsuruya, Toshiaki Nakano, Yuta Matsukuma, Takanari Kitazono, Hiroaki Tsujikawa, Masatoshi Hara, Kumiko Torisu
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCES. 24(2)
Bilirubin is recognized as an endogenous antioxidant, and low serum bilirubin is reported to be associated with the progression of kidney disease. However, it is unclear whether serum bilirubin levels are associated with the loss of residual kidney f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cca6d2563b5253cd9b0571db96e3dd9
https://pubmed.ncbi.nlm.nih.gov/31207066
https://pubmed.ncbi.nlm.nih.gov/31207066
Autor:
Yasuhiro Kawai, Takanari Kitazono, Hiroaki Tsujikawa, Hisako Yoshida, Shigeru Tanaka, Kazuhiko Tsuruya, Masatoshi Hara
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 39(2)
BackgroundResidual kidney function (RKF) is an important factor influencing both technique and patient survival in peritoneal dialysis (PD) patients. B-type natriuretic peptide (BNP) is considered a marker of cardio-renal syndrome. The relationship b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d52352ebb0ba0c5088879112b8fa4efb
https://pubmed.ncbi.nlm.nih.gov/30478140
https://pubmed.ncbi.nlm.nih.gov/30478140
Autor:
Kazuhiko Tsuruya, Hiroaki Tsujikawa, Shigeru Tanaka, Toshiaki Nakano, Yuta Matsukuma, Kumiko Torisu, Takanari Kitazono, Hidetoshi Kanai
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 3, p e0213922 (2019)
PLoS ONE, Vol 14, Iss 3, p e0213922 (2019)
BackgroundAssessment of infection-related mortality remains inadequate in patients undergoing peritoneal dialysis. This study was performed to develop a risk model for predicting the 2-year infection-related mortality risk in patients undergoing peri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4647a6062900863224ef666f31269784
https://doi.org/10.1371/journal.pone.0213922
https://doi.org/10.1371/journal.pone.0213922